205818-25-3Relevant academic research and scientific papers
Naphthyl compounds and compositions, as estrogen receptor binding agents
-
, (2008/06/13)
The invention provides a compound of formula I: STR1 or a pharmaceutically acceptable salt or solvate thereof; pharmaceutical compositions containing a compound of formula I, and methods of using a compound of formula I for inhibiting bone loss or bone resorption, particularly osteoporosis, and cardiovascular-related pathological conditions including hyperlipidemia, and estrogen dependent cancer.
Naphthyl compounds, compositions, and methods
-
, (2008/06/13)
The invention provides naphthyl compounds, formulations, and methods of inhibiting bone loss or bone resorption, particularly osteoporosis, and cardiovascular-related pathological conditions including hyperlipidemia, and estrogen-dependent cancer.
